tt3a — Transcatheter Ascending Aortic Repair

TT3A is an innovative Italy-based MedTech startup pioneering the development of the world’s first structural heart device specifically designed for the endovascular treatment of ascending aortic aneurysms and dissections.

Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and safety, setting the stage for transformative solutions in aortic care.